Applied Dna Sciences Inc (NASDAQ:BNBX) Short Interest Update

Applied Dna Sciences Inc (NASDAQ:BNBXGet Free Report) was the recipient of a significant increase in short interest during the month of June. As of June 30th, there was short interest totaling 173,283 shares, an increase of 213.0% from the June 15th total of 55,360 shares. Currently, 2.6% of the shares of the company are short sold. Based on an average trading volume of 271,228 shares, the days-to-cover ratio is currently 0.6 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Applied Dna Sciences in a research report on Friday, April 24th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Applied Dna Sciences currently has an average rating of “Sell”.

Read Our Latest Stock Report on BNBX

Applied Dna Sciences Price Performance

Shares of BNBX stock traded down $0.21 during trading on Monday, reaching $0.17. 3,021,774 shares of the company’s stock traded hands, compared to its average volume of 537,925. The company has a market capitalization of $1.19 million, a P/E ratio of -0.00 and a beta of 0.52. The stock has a 50-day moving average price of $0.44. Applied Dna Sciences has a 1 year low of $0.15 and a 1 year high of $7.15.

Applied Dna Sciences (NASDAQ:BNBXGet Free Report) last released its quarterly earnings data on Friday, May 15th. The company reported ($0.68) earnings per share for the quarter. The business had revenue of $1.02 million during the quarter. Applied Dna Sciences had a negative net margin of 1,647.25% and a negative return on equity of 349.95%.

About Applied Dna Sciences

(Get Free Report)

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.

Further Reading

Receive News & Ratings for Applied Dna Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Dna Sciences and related companies with MarketBeat.com's FREE daily email newsletter.